Anne E Richter1, Arend F Bos2, E Angela Huiskamp3, Elisabeth M W Kooi2. 1. Division of Neonatology, University of Groningen, University Medical Center Groningen, Beatrix Children's Hospital, Groningen, The Netherlands, a.e.richter@umcg.nl. 2. Division of Neonatology, University of Groningen, University Medical Center Groningen, Beatrix Children's Hospital, Groningen, The Netherlands. 3. Department of Ophthalmology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Abstract
BACKGROUND: High arterial oxygen saturation (SaO2) is associated with the development of retinopathy of prematurity (ROP), but difficult to avoid. OBJECTIVE: To assess the association between severe ROP and a burden of cerebral and arterial hyperoxia. METHODS: We retrospectively analyzed 225 preterm infants born ≤30 weeks' gestation. The cerebral oxygen saturation (rcSO2) and SaO2 were measured within the first 96 h after birth. We determined the burden of both cerebral and arterial hyperoxia, which was defined as the percentage of time spent at saturation thresholds exceeding 85 and 90%, respectively. Their association with severe ROP (prethreshold disease type 1) was tested using logistic regression analyses. RESULTS: Median gestational age (GA) was 28.0 weeks (interquartile range 26.7-29.0) and mean birth weight 1,032 g (±281 SD). Eight infants developed severe ROP. Infants with severe ROP spent more time at cerebral hyperoxic levels than infants without severe ROP (medians 30 vs. 16%). Adjusted for GA, for every 10% increase in burden of cerebral hyperoxia, the OR for developing ROP was 1.50 (95% CI 1.09 - 2.06, p = 0.013). A burden of arterial hyperoxia was not associated with ROP. Infants with severe ROP experienced even less arterial hyperoxia, although not statistically significant. CONCLUSIONS: Cerebral hyperoxia may be a better early predictor of severe ROP than arterial hyperoxia. Moreover, under strict oxygen management, cerebral hyperoxia in these infants may result from cerebral immaturity rather than a high SaO2. Whether reducing cerebral hyperoxia is feasible and might prevent ROP needs to be further examined.
BACKGROUND: High arterial oxygen saturation (SaO2) is associated with the development of retinopathy of prematurity (ROP), but difficult to avoid. OBJECTIVE: To assess the association between severe ROP and a burden of cerebral and arterial hyperoxia. METHODS: We retrospectively analyzed 225 preterm infants born ≤30 weeks' gestation. The cerebral oxygen saturation (rcSO2) and SaO2 were measured within the first 96 h after birth. We determined the burden of both cerebral and arterial hyperoxia, which was defined as the percentage of time spent at saturation thresholds exceeding 85 and 90%, respectively. Their association with severe ROP (prethreshold disease type 1) was tested using logistic regression analyses. RESULTS: Median gestational age (GA) was 28.0 weeks (interquartile range 26.7-29.0) and mean birth weight 1,032 g (±281 SD). Eight infants developed severe ROP. Infants with severe ROP spent more time at cerebral hyperoxic levels than infants without severe ROP (medians 30 vs. 16%). Adjusted for GA, for every 10% increase in burden of cerebral hyperoxia, the OR for developing ROP was 1.50 (95% CI 1.09 - 2.06, p = 0.013). A burden of arterial hyperoxia was not associated with ROP. Infants with severe ROP experienced even less arterial hyperoxia, although not statistically significant. CONCLUSIONS:Cerebral hyperoxia may be a better early predictor of severe ROP than arterial hyperoxia. Moreover, under strict oxygen management, cerebral hyperoxia in these infants may result from cerebral immaturity rather than a high SaO2. Whether reducing cerebral hyperoxia is feasible and might prevent ROP needs to be further examined.
Authors: Ben J Stenson; William O Tarnow-Mordi; Brian A Darlow; John Simes; Edmund Juszczak; Lisa Askie; Malcolm Battin; Ursula Bowler; Roland Broadbent; Pamela Cairns; Peter Graham Davis; Sanjeev Deshpande; Mark Donoghoe; Lex Doyle; Brian W Fleck; Alpana Ghadge; Wendy Hague; Henry L Halliday; Michael Hewson; Andrew King; Adrienne Kirby; Neil Marlow; Michael Meyer; Colin Morley; Karen Simmer; Win Tin; Stephen P Wardle; Peter Brocklehurst Journal: N Engl J Med Date: 2013-05-05 Impact factor: 91.245
Authors: Lisa M Askie; Brian A Darlow; Peter G Davis; Neil Finer; Ben Stenson; Maximo Vento; Robin Whyte Journal: Cochrane Database Syst Rev Date: 2017-04-11
Authors: Anne M Plomgaard; Thomas Alderliesten; Topun Austin; Frank van Bel; Manon Benders; Olivier Claris; Eugene Dempsey; Monica Fumagalli; Christian Gluud; Cornelia Hagmann; Simon Hyttel-Sorensen; Petra Lemmers; Wim van Oeveren; Adelina Pellicer; Tue H Petersen; Gerhard Pichler; Per Winkel; Gorm Greisen Journal: PLoS One Date: 2017-03-22 Impact factor: 3.240
Authors: Lisa M Askie; Brian A Darlow; Neil Finer; Barbara Schmidt; Ben Stenson; William Tarnow-Mordi; Peter G Davis; Waldemar A Carlo; Peter Brocklehurst; Lucy C Davies; Abhik Das; Wade Rich; Marie G Gantz; Robin S Roberts; Robin K Whyte; Lorrie Costantini; Christian Poets; Elizabeth Asztalos; Malcolm Battin; Henry L Halliday; Neil Marlow; Win Tin; Andrew King; Edmund Juszczak; Colin J Morley; Lex W Doyle; Val Gebski; Kylie E Hunter; Robert J Simes Journal: JAMA Date: 2018-06-05 Impact factor: 56.272
Authors: Wouter B Vehmeijer; Vigdis Magnusdottir; Thorunn S Eliasdottir; Sveinn Hakon Hardarson; Nicoline E Schalij-Delfos; Einar Stefánsson Journal: PLoS One Date: 2016-02-03 Impact factor: 3.240